Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses

BACKGROUND: Some cancer patients are immuno-compromised, and it has been long felt that immune-intervention is not compatible with standard chemotherapies. However, increasing evidence suggests that standard chemotherapy drugs may stimulate beneficial changes in both the immune system and tumour. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, W M, Fowler, D W, Smith, P, Dalgleish, A G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813751/
https://www.ncbi.nlm.nih.gov/pubmed/19997099
http://dx.doi.org/10.1038/sj.bjc.6605465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813751/
https://www.ncbi.nlm.nih.gov/pubmed/19997099
http://dx.doi.org/10.1038/sj.bjc.6605465

Ejemplares similares